Assignee
JAPAN CHEM RES
JP·78 granted patents·39 pending applications·1,159 citations·filing 1983–2024
Top patents by PatentIndex Score
117 records- 0199US11111308B2Anti-human transferrin receptor antibody capable of penetrating blood-brain barrierJAPAN CHEM RES·Filed 2020·Granted Sep 7, 2021·13 cites·47 claims
- 0298US10759864B2Anti-human transferrin receptor antibody capable of penetrating blood-brain barrierJAPAN CHEM RES·Filed 2017·Granted Sep 1, 2020·17 cites·43 claims
- 0397US6653466B2Pharmaceutical composition for treatment of duchenne muscular dystrophyJAPAN CHEM RES·Filed 2001·Granted Nov 25, 2003·132 cites·16 claims
- 0497US4609546ALong-acting compositionJAPAN CHEM RES·Filed 1983·Granted Sep 2, 1986·485 cites·15 claims
- 0595US6727355B2Pharmaceutical composition for treatment of Duchenne muscular dystrophyJAPAN CHEM RES·Filed 2001·Granted Apr 27, 2004·152 cites·2 claims
- 0693US11248045B2Anti-human transferrin receptor antibody permeating blood-brain barrierJAPAN CHEM RES·Filed 2016·Granted Feb 15, 2022·7 cites·6 claims
- 0793US11130815B2Fusion proteins containing a BDNF and an anti-human transferrin receptor antibodyJAPAN CHEM RES·Filed 2016·Granted Sep 28, 2021·5 cites·22 claims
- 0890US10940185B2Lyophilized preparationJAPAN CHEM RES·Filed 2017·Granted Mar 9, 2021·11 cites·29 claims
- 0989US11634474B2Human serum albumin mutantJAPAN CHEM RES·Filed 2021·Granted Apr 25, 2023·2 cites·13 claims
- 1089US11046751B2Human serum albumin mutantJAPAN CHEM RES·Filed 2020·Granted Jun 29, 2021·2 cites·14 claims
- 1187US10654912B2Human serum albumin mutantJAPAN CHEM RES·Filed 2016·Granted May 19, 2020·3 cites·4 claims
- 1286US9994641B2Anti-human transferrin receptor antibody that passes through blood-brain barrierJAPAN CHEM RES·Filed 2014·Granted Jun 12, 2018·16 cites·10 claims
- 1386US2025026846A1Novel Anti-Human Transferrin Receptor Antibody Capable of Penetrating Blood-Brain BarrierJAPAN CHEM RES·Filed 2024·Application pending·0 cites
- 1481US2024219372A1Analytical method for glycosaminoglycansJAPAN CHEM RES·Filed 2024·Application pending·0 cites
- 1581US2024262926A1Fusion Protein Containing BDNFJAPAN CHEM RES·Filed 2024·Application pending·0 cites
- 1678US7402150B2Injection deviceJAPAN CHEM RES·Filed 2006·Granted Jul 22, 2008·33 cites·10 claims
- 1777US12145995B2Anti-human transferrin receptor antibody capable of penetrating blood-brain barrierJAPAN CHEM RES·Filed 2021·Granted Nov 19, 2024·0 cites·38 claims
- 1877US11932699B2Aqueous pharmaceutical compositionJAPAN CHEM RES·Filed 2018·Granted Mar 19, 2024·2 cites·1 claims
- 1976US2024245797A1Method for Delivering Drug to MuscleJAPAN CHEM RES·Filed 2024·Application pending·0 cites
- 2075US9657310B2Expression vectorJAPAN CHEM RES·Filed 2013·Granted May 23, 2017·2 cites·16 claims
- 2174US11958905B2Fusion proteins containing a BDNF and an anti-human transferrin receptor antibodyJAPAN CHEM RES·Filed 2021·Granted Apr 16, 2024·0 cites·27 claims
- 2269US11649474B2Method for producing glycoprotein having mannose residue as non-reducing end of sugar chainJAPAN CHEM RES·Filed 2019·Granted May 16, 2023·0 cites·14 claims
- 2369US9617529B2Method for production of recombinant human alpha-galactosidase AJAPAN CHEM RES·Filed 2013·Granted Apr 11, 2017·1 cites·10 claims
- 2468US7338776B2Production of UGPPaseJAPAN CHEM RES·Filed 2003·Granted Mar 4, 2008·5 cites·13 claims
- 2568US2025257338A1Glycoprotein having reduced number of mannose-6-phosphatesJAPAN CHEM RES·Filed 2023·Application pending·0 cites
- 2667US8348902B2Syringe holder and injection deviceJAPAN CHEM RES·Filed 2006·Granted Jan 8, 2013·8 cites·12 claims
- 2767US2022064288A1Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain BarrierJAPAN CHEM RES·Filed 2021·Application pending·0 cites
- 2867US2024335432A1Therapeutic compound for neuronal ceroid lipofuscinosisJAPAN CHEM RES·Filed 2022·Application pending·0 cites
- 2967US2025381296A1Nucleic Acid Molecule, Vector, Recombinant Cells, and Drug for Treating Central Nervous System DiseaseJAPAN CHEM RES·Filed 2023·Application pending·0 cites
- 3066USRE50240EAnti-human transferrin receptor antibody capable of penetrating blood-brain barrierJAPAN CHEM RES·Filed 2017·Granted Dec 24, 2024·0 cites·45 claims
- 3165US12178858B2Lyophilized preparationJAPAN CHEM RES·Filed 2021·Granted Dec 31, 2024·0 cites·11 claims
- 3265US10557115B2Medium containing uridine and N-acetyl-D-mannosamineJAPAN CHEM RES·Filed 2019·Granted Feb 11, 2020·0 cites·24 claims
- 3365US2024076600A1Cell culture device and parallel filter connectorJAPAN CHEM RES·Filed 2022·Application pending·0 cites
- 3464US2025333481A1Fusion protein of serum albumin and physiologically-active proteinJAPAN CHEM RES·Filed 2023·Application pending·0 cites
- 3563US7166764B2Noc2 knockout mouseJAPAN CHEM RES·Filed 2005·Granted Jan 23, 2007·2 cites·10 claims
- 3663US7115797B2Mice lacking inward-rectifying potassium channel Kir6.1JAPAN CHEM RES·Filed 2003·Granted Oct 3, 2006·1 cites·1 claims
- 3763US4528186AMethod of producing human epidermal growth factorJAPAN CHEM RES·Filed 1983·Granted Jul 9, 1985·20 cites·8 claims
- 3863US2024233127A1Analysis software and apparatus for screening early embryoJAPAN CHEM RES·Filed 2024·Application pending·0 cites
- 3963US2024150726A1Method for Producing Recombinant AAV9 VirionJAPAN CHEM RES·Filed 2022·Application pending·0 cites
- 4062US7235253B2Powder containing physiologically active peptideJAPAN CHEM RES·Filed 2001·Granted Jun 26, 2007·1 cites·2 claims
- 4162US5547945ARemitting agent for nephrotic syndrome and hepatopathy symptomsJAPAN CHEM RES·Filed 1994·Granted Aug 20, 1996·16 cites·7 claims
- 4262US2023060797A1Therapeutic compound for neuronal ceroid lipofuscinosisJAPAN CHEM RES·Filed 2021·Application pending·0 cites
- 4361US11938464B2Analytical method for sugar chains having acidic groupsJAPAN CHEM RES·Filed 2022·Granted Mar 26, 2024·0 cites·7 claims
- 4461US2021132040A1Analytical method for glycosaminoglycansJAPAN CHEM RES·Filed 2018·Application pending·0 cites
- 4559US7067265B2Sodium ion-driven chloride/bi-carbonate exchangerJAPAN CHEM RES·Filed 2003·Granted Jun 27, 2006·0 cites·11 claims
- 4659US6548284B1Membrane-bound metalloprotease and soluble secreted form thereofJAPAN CHEM RES·Filed 2000·Granted Apr 15, 2003·3 cites·9 claims
- 4758US2021038739A1Method for Delivering Drug to MuscleJAPAN CHEM RES·Filed 2019·Application pending·0 cites
- 4858US2025059292A1Fusion Protein of Anti-Transferrin Receptor Antibody and Physiologically Active Protein for Safe Gene TherapyJAPAN CHEM RES·Filed 2022·Application pending·0 cites
- 4958US2024269244A1Pharmaceutical Composition for Treatment of Mucopolysaccharidosis Type 1JAPAN CHEM RES·Filed 2022·Application pending·0 cites
- 5056US11738068B2Protein-containing aqueous liquid formulationJAPAN CHEM RES·Filed 2019·Granted Aug 29, 2023·0 cites·4 claims
Showing the top 50 of 117 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when JAPAN CHEM RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →